Company
The people and the plan behind Lävi Delta.
Lävi Clinical Suite OÜ is a medical software company in Tartu, Estonia. We are building Lävi Delta as a medical device under the EU Medical Device Regulation — slowly enough to do it properly.
Clinical validation and regulatory development in progress · not CE-marked
01 — Team
Who we are
-
Andreas Müürsepp — Founder & CEO
Neuroradiologist. Andreas reads longitudinal brain MRI clinically and drove the design of the Lävi Delta pipeline from its first version, so the reading-room problem and the software stay unusually close.
-
Alvar Haug — Co-founder & CTO
Runs infrastructure, deployment and security — the plumbing a clinical system stands on, and the first thing a hospital IT department asks about.
-
Anna-Liisa Rossi — COO
Runs operations: partnerships with hospitals, coordination of the planned reader study and the day-to-day work that keeps a regulated product on schedule.
The company is deliberately built on three legs: neuroradiology and clinical workflow, software and infrastructure engineering, and clinical validation: the reference standard of the planned reader study is set by two neuroradiologists who do not see the software's output, and the analysis plan is fixed before the study starts.
The team is growing. If your work touches medical imaging, clinical software or regulatory affairs, see careers.
02 — Roadmap
What comes next
Lävi Delta is the first product, not the whole plan. What it establishes — lining up scans taken at different times, the quality check that withholds a result when two scans cannot fairly be compared, a record of how every result was produced, the connection to hospital imaging systems, the review screen and the way the product is evaluated clinically — is the foundation each later product reuses rather than rebuilds.
Lävi Delta
Longitudinal brain MRI review. The present development, clinical-validation and regulatory focus — and the platform everything after it stands on.
Lävi MS
A dedicated multiple sclerosis imaging workflow, building on the longitudinal, quality-control and validation infrastructure established with Lävi Delta. Its own programme begins once Delta's reaches the required maturity.
Further longitudinal workflows
Later longitudinal brain MRI products can reuse the same quality checks, result records and hospital installation. None are announced beyond Lävi MS — the platform is the point, not a product list.
Status as of 2026-11-17